ISRCTN27398531已完成不适用
Efficacy of EPs 7630 compared to placebo in children with acute non-streptococcal tonsillopharyngitis
ISO Arzneimittel GmbH & Co KG (Germany)0 个研究点目标入组 124 人开始时间: 2003年3月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 124
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients who met the following inclusion criteria were suitable for the trial:
- •1. Age 6 - 10 years, acute tonsillopharyngitis, duration of complaints less than 48 hours, negative dip-and-react-test test for beta-hemolytic streptococcus and severity of symptoms greater than or equal to 8 points
- •2. In addition legal guardians had to sign an informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Efficacy of EPs 7630 compared to placebo in the treatment of acute bronchitisBronchitisAcute bronchitisRespiratoryISRCTN60790910ISO Arzneimittel GmbH & Co KG (Germany)205
已完成
不适用
Efficacy of EPs 7630 in children with acute non-streptococcal tonsillopharyngitisAcute tonsillopharyngitisRespiratoryTonsillopharyngitisISRCTN86579667ISO Arzneimittel GmbH & Co KG (Germany)78
未知
1 期
A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitisatopic dermatitisJPRN-jRCT2080222693Eisai Co., Ltd.24
已完成
不适用
Efficacy of EPs 7630 in acute non-streptococcal tonsillopharyngitisISRCTN03930168ISO Arzneimittel GmbH & Co KG (Germany)60
进行中（未招募）
不适用
Exploratory study of S 38093 versus placebo in patients with mild to moderate Alzheimer’s Disease.An international, multi-centre, randomised, double-blind, placebo-controlled phase IIa study.Alzheimer's diseaseEUCTR2008-007670-37-ATInstitut de Recherches Internationales Servier200